01 Identity and provenance
- Accepted binomial
- Vitex agnus-castus
- Common names
- Chaste Tree
- Family (APG IV)
- Lamiaceae
- Part used
- Fruit
- Verification tier
- Tier 2 · Verified Clinical columns reviewed and a source is on record.
- Reviewer note (2026 audit)
- Front Endocrinol 2023;14:1269781. doi:10.3389/fendo.2023.1269781 | Drugs.com NPP Chaste Tree monograph | VERIFIED 2026 - synthetic analogue, application, interactions, side effects and references populated from retrieved primary/regulatory sources (see References). Interaction entries are labelled CLINICAL (case reports or trials in humans) vs THEORETICAL (in-vitro or animal only). Marketed-formulation column intentionally left blank. | INTERACTION
02 Constituent chemistry
| Chemical class | Marker compound | Synthetic analogue in use |
|---|---|---|
| Iridoid glycosides | Agnuside
Fruit
|
Bromocriptine, Cabergoline (FUNCTIONAL - dopamine D2 receptor agonism lowering prolactin). No structural analogue. |
The analogue column is what makes the interaction reasoning tractable: where a constituent has a marketed structural counterpart, the counterpart's interaction profile is the starting hypothesis for the plant.
03 Stated application
- Reported activity
- Premenstrual syndrome, PMDD, cyclical mastalgia, menstrual irregularity and latent hyperprolactinaemia. Clerodadienol-type diterpenes bind pituitary D2 receptors and suppress prolactin release.
- Reported adverse effects
- Gastrointestinal upset, headache, dizziness, acne, rash. Avoid in pregnancy and breastfeeding. Caution in hormone-sensitive conditions.
04 Interaction matrix
Source column, verbatim: CLINICAL: dopamine agonists and antagonists (antipsychotics, metoclopramide). HORMONAL - the Australian TGA issued a safety advisory (2 May 2019) on potential interaction with oral contraceptives; reduced contraceptive efficacy cannot be excluded. Health Canada carries warnings on hormone-containing medicines.
Normalised onto 2 canonical drug classes below.
Curated from the reviewed source
| Drug class | Severity | Mechanism type | Provenance | Expected effect | |
|---|---|---|---|---|---|
|
Antipsychotics
CNS
|
3Major | PD-additive + PK-CYP | curated A | Extrapyramidal symptoms, QT prolongation, excess sedation, or loss of ant… | why ▾ |
Class mechanism. Additive dopaminergic blockade, QT prolongation and sedation, plus CYP1A2, 2D6 and 3A4 modulation of clozapine, risperidone and quetiapine exposure.
| |||||
|
Hormonal therapy, oral contraceptives and HRT
Endocrine
|
3Major | PK-CYP3A4 induction + PD-oestrogenic | curated A | Breakthrough bleeding and contraceptive failure; unpredictable effect in … | why ▾ |
Class mechanism. CYP3A4-inducing botanicals accelerate ethinylestradiol and progestin clearance. Separately, isoflavone, lignan and coumestan phyto-oestrogens bind oestrogen receptors and may add to or compete with prescribed hormones.
| |||||
05 Hazard register
06 Confusable material
These entries could be mistaken for this one in trade, in the herbarium, or in a prescription. Powdered material is often indistinguishable, so the check is macroscopic, microscopic and chromatographic rather than nominal.
| Vitex negundo
Nirgundi |
Lamiaceae | Same genus (Vitex) |
07 Mechanism map
Chemistry sorts to the left, pharmacology to the right. Dashed edges are predicted. Drag nodes, scroll to zoom, export at 3× for a figure.
08 Open literature
Abstract-scoped query built from this binomial, its common names and its marker compounds, run live against Europe PMC, PubMed and OpenAlex, then ranked locally against an evidence hierarchy.
09 Isomechanistic neighbours
Species whose interaction profile overlaps this one, ranked by shared severity weight rather than by count — a shared contraindication counts for more than a shared minor signal. Practical use: these are the plants you should not stack with this one, because the mechanisms summate.
| Species | Family | Shared classes | Weight | Jaccard |
|---|---|---|---|---|
| Serenoa repens
Saw Palmetto |
Arecaceae | 1 | 0.25 | |
| Gymnema sylvestre
Gurmar |
Apocynaceae | 1 | 0.25 | |
| Tribulus terrestris
Gokshura |
Zygophyllaceae | 1 | 0.25 | |
| Achyranthes aspera
Apamarga |
Amaranthaceae | 1 | 0.25 | |
| Sapindus mukorossi
Reetha |
Sapindaceae | 1 | 0.25 | |
| Sesamum indicum
Til (Sesame) |
Pedaliaceae | 1 | 0.25 |
10 References and notes
Source column: TGA safety advisory, 2 May 2019 (oral contraceptive interaction)
TGA safety advisory, 2 May 2019 (oral contraceptive interaction)
BibTeX for all 1 records
@article{anon2019,
title = {TGA safety advisory, 2 May 2019 (oral contraceptive interaction)},
year = {2019},
}
Curator notes
No notes yet.
Sign in to add notes and save monographs.